Mackay Shields LLC’s Collegium Pharmaceutical COLL Stock Holding History

Mackay Shields LLC’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-120,400	Closed	-$2.11M	–	1448
2020 Q2	$2.11M	Buy	120,400 +81,400	+209%	+$1.59M	0.02%	725
2020 Q1	$637K	Sell	39,000 -98,500	-72%	-$2.03M	0.01%	1079
2019 Q4	$2.83M	Buy	+137,500	New	+$2.29M	0.02%	728
2019 Q3	–	Sell	-195,636	Closed	-$2.57M	–	1416
2019 Q2	$2.57M	Buy	195,636 +153,036	+359%	+$2.05M	0.02%	802
2019 Q1	$645K	Buy	42,600 +31,900	+298%	+$511K	﹤0.01%	1119
2018 Q4	$183K	Sell	10,700 -11,800	-52%	-$202K	﹤0.01%	1323
2018 Q3	$332K	Buy	+22,500	New	+$399K	﹤0.01%	1048

Other funds holding COLL

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Mackay Shields LLC's COLL Position: Q3 2020 in Review

Mackay Shields LLC sold out of Collegium Pharmaceutical (COLL) in Q3 2020, closing a stake of 120,400 shares — an estimated $2.11M sold.

Mackay Shields LLC first reported a position in COLL in Q3 2018 and held it in 7 quarters. The position peaked at $2.83M in Q4 2019. 140 funds tracked by Wall St. Rank hold COLL as of Q3 2020.

Mackay Shields LLC reported no remaining Collegium Pharmaceutical position as of Q3 2020 after selling out during the quarter.
Mackay Shields LLC sold 120,400 Collegium Pharmaceutical shares in Q3 2020, an estimated $2.11M.
Mackay Shields LLC first reported a position in Collegium Pharmaceutical in Q3 2018 and held it in 7 quarters.
Mackay Shields LLC's Collegium Pharmaceutical position peaked at $2.83M in Q4 2019.
140 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.